Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 USD | 0.00% |
|
-1.68% | -37.77% |
05-15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
05-14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on IO Biotech, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering IO Biotech, Inc.
HC Wainwright | |
Piper Sandler | |
Morgan Stanley | |
Jefferies & Co. | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- IOBT Stock
- Consensus IO Biotech, Inc.